NCT06414135 Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis Status RECRUITING Phase PHASE1
NCT06412614 Evaluation of Patients With Systemic Sclerosis Without Specific or Associated Autoantibodies Status NOT_YET_RECRUITING Phase N/A
NCT06400303 KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06379646 An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease Status RECRUITING Phase NA
NCT06373263 Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1 Status NOT_YET_RECRUITING Phase NA
NCT06373081 Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease Status RECRUITING Phase NA
NCT06361745 Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases Status RECRUITING Phase NA
NCT06350110 Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) Status RECRUITING Phase PHASE1/PHASE2
NCT06347718 CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease Status RECRUITING Phase PHASE1/PHASE2
NCT06333795 Faecal Microbiota Transplantation Against Chronic Diarrhea in Patients With Systemic Sclerosis Status ACTIVE_NOT_RECRUITING Phase NA
NCT06328777 RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis Status RECRUITING Phase PHASE1/PHASE2
NCT06316076 Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases Status RECRUITING Phase PHASE1
NCT06297096 Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease Status RECRUITING Phase PHASE3
NCT06291142 Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot Status COMPLETED Phase N/A
NCT06231433 Effects of Fractional CO2 Laser Treatment on Vaginal Symptoms and Sexual Dysfunction in Women With Systemic Sclerosis Status COMPLETED Phase PHASE2/PHASE3
NCT06210945 Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic Sclerosis Status SUSPENDED Phase PHASE2
NCT06155578 Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06133244 Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME) Status RECRUITING Phase N/A
NCT06095921 The Effect of a Self-Management Program on Individuals With Scleroderma Status COMPLETED Phase NA
NCT06058091 RY_SW01 Cell Injection Therapy in Systemic Sclerosis Status RECRUITING Phase PHASE1/PHASE2